In the Aug. 24 issue, DSN also highlighted some of the companies attracting — and retaining — New General Market consumers, including Ansell, Beiersdorf, Dentek, Fleet, hello products, Kao Brands, Mentholatum, Paris Presents and Wahl.
Fifty years ago this summer, President Lyndon B. Johnson secured his place in history by signing into law the legislation that created Medicare and Medicaid. To commemorate the anniversary, Drug Store News has put together an exclusive report on the effect that Medicare and Medicaid have had on the retail pharmacy industry and how it has transformed the role of the pharmacist.
When Drug Store News last profiled Rite Aid in 2012, the company was posting its best results in years and completing a historic turnaround that saw the chain traveling full speed ahead on its Road to Wellness.
In this exclusive 20-page special report, DSN examines Walmart’s mission to be America’s destination for health and wellness — and the leadership team charting the course. Walmart executives — including president of health and wellness Labeed Diab, SVP of baby, paper goods, chemicals, OTC and optical Carmen Bauza, and others share the company's vision in pharmacy, OTC, specialty pharmacy, retail clinics, optical and more.
DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a look at FDA reform and its potential impact on healthcare costs, in this multi-page report.
Drug Store News in November presented Walgreens president of pharmacy, health and wellness Kermit Crawford — who will retire from the company at the end of the year, after 31 years at Walgreens — with the first-ever DSN Pharmacy Innovator award. In the December issue, DSN examines Crawford’s career and some of the major contributions he has made to Walgreens and community pharmacy along the way.
DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a look at the impact of the Hatch-Waxman act and Q&A's with industry leaders, in this multi-page report.
In terms of boosting medication adherence and prescription volumes, the benefits of consolidating all of a patient’s prescriptions into a single, once-a-month refill process are even greater than previously thought.
DSN looks back on the past year's most influential events in the pharmacy industry, from Obamacare and record patent expirations to Humira surpassing Lipitor as the world's top-selling drug and the merger of Walgreens and Alliance Boots.
After a two-year, top-to-bottom makeover — and a relentless focus on its core customers and its broad mission as a health, wellness and convenient shopping destination — the company that wants to “own well” has honed its message to consumers: Walgreens is ready to be the nation’s top wellness destination.
As the costs of primary care march steadily higher and patients endure ever-longer wait times to see a family physician, the need for accessible, cost-effective patient care alternatives has become both obvious and urgent.
Enter Walgreens. Armed with new, time-saving pharmacy automation tools, a growing offsite-dispensing capability and an array of new adherence and disease-management services, the company heavily is promoting its pharmacists and in-store clinicians as the most cost-effective front-line resource for community-based patient care.